SCHEMBL5577587

SCHEMBL5577587

Cc1c(Cl)cccc1C(=O)NCc1scnc1C1CCN(Cc2ccc(F)cc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.45
P2RX7 Q99572 5/20 0.43
TP53 P04637 2/20 0.41
DRD3 P35462 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HTR4 Q13639 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CYP2C9 P11712 1/20 0.41
ADRA2B P18089 1/20 0.41
HTR2C P28335 1/20 0.41
SLC6A4 P31645 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTR2B P41595 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577431 0.96 MT-CO2 (0.46) MT-CO2P2RX7TP53DRD3HTR4
SCHEMBL5577591 0.88 DRD4 (0.42) DRD3HTR4SIGMAR1DRD2DRD4
SCHEMBL5577773 0.85 MT-CO2 (0.45) MT-CO2P2RX7TP53DRD3MEN1
SCHEMBL5577640 0.84 HTR4 (0.43) DRD3MEN1KMT2AHTR4LMNA
SCHEMBL5577554 0.83 MT-CO2 (0.55) MT-CO2TP53DRD3MEN1KMT2A
SCHEMBL5577671 0.83 MT-CO2 (0.43) MT-CO2P2RX7DRD3MEN1KMT2A
SCHEMBL5577720 0.83 MT-CO2 (0.44) MT-CO2TP53DRD3MEN1KMT2A
SCHEMBL5577358 0.83 DRD2 (0.46) MEN1KMT2AHTR2CKCNH2SIGMAR1
SCHEMBL5577558 0.82 MT-CO2 (0.47) MT-CO2TP53PRKAA2
SCHEMBL5577582 0.82 MT-CO2 (0.47) MT-CO2TP53DRD3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C MT-CO2 2047/4885P2RX7 1272/4885TP53 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.